Inventor
CHRISTOPH GIBSON
Inventor
DE
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
Y02ATechnologies for adaptation to climate change14%
PatentTitleYear
12,391,681(R)-3-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)morpholine derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases202512,312,3301-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases202511,820,756Bradykinin B2 receptor antagonists202311,261,173Bradykinin B2 receptor antagonists2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to PHARVARIS NETHERLANDS B V (2)· patent assignee history
2022–2025Based in DE· patent location history
2025Patents assigned to PHARVARIS GMBH (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PHARVARIS GMBH | 2 | 2025 |
| PHARVARIS NETHERLANDS B V | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 4 | 2022–2025 |